4Iwashima Y,Katsuya T,Ishikawa K,et al.Hypoadiponectinemia is an independent risk factor for hypertension[J].Hypertension,2004;43(6):1318-23.
5Chang LC,Huang KC,Wu YW,et al.The clinical implications of blood adiponectin in cardiometabolic disorders[J].J Formos Med Assoc,2009;108(5):353-66.
6Pitt B,Byington RP,Furberg CD,et al.Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events[J].Circulation,2000;102(13):1503-10.
7Hattori Y,Suzuki M,Hattori S,et al.Globular adiponectin upregulates nitric oxide production in vascular endothelial cells[J].Diabetologia,2003;46(11):1543-9.
8Ouchi N,Kihara S,Arita Y,et al.Adiponectin,an adipocyte-derived plasma protein,inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway[J].Circulation,2000;102(11):1296-301.
9Ouchi N,Kihara S,Funahashi T,et al.Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue[J].Circulation,2003;107(5):671-4.
4Papadopoulos DP, Perrea D, Thomopoulos C, et al.Maskedhypertension and atherogenesis: the impact on adiponectinand resistin plasma levels[J].J Clin Hypertens (Greenwich),2009’ 11(2): 61-65.
5Blanco-Colio LM,Osende JI,Martin-Ventura JL,et al.gtatins in hypertensive patients:pot ential explanat ions for the ASCOT-LLA st udy results[J]. Drug, 2004,64(2): 61-67.
6WHO-ISH,Hypertension Guidelines Committee. 1990 world health organization-international society of hypertension guidelines for the management of hypertension[J].Journal of Hypertension,2011,(09):151-183.
7Huan Gui,Yong‐Fei Guo,Xia Liu,Jing‐Ming Zhang,Yan‐Ling Yang,Gao‐Zhong Huang,Jian‐Guo Liu.Effects of Combination Therapy with Levamlodipine and Bisoprolol on Stroke in Rats[J].CNS Neurosci Ther.2013(3)
8Zuojia Liu,Xiliang Zheng,Xiurong Yang,Erkang Wang,Jin Wang.Affinity and Specificity of Levamlodipine-Human Serum Albumin Interactions: Insights into Its Carrier Function[J].Biophysical Journal.2009(10)
